loading

Kiora Pharmaceuticals Inc Azioni (KPRX) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
66.85%
0.7944
2.3962 2.3304 2.5647 3.6022
Operating Income/Loss
66.85%
-0.7944
-2.3962 -2.3304 -2.5647 -3.6022
Nonoperating Income/Loss
35.26%
0.1781
0.1317 0.2604 0.4062 0.1889
Income/Loss From Continuing Operations Before Tax
72.78%
-0.6163
-2.2645 -2.07 -10.36 -3.4133
Income Tax Expense/Benefit
473.93%
-0.6431
-0.1121 0.123 - -
Income/Loss From Continuing Operations After Tax
101.25%
0.0268
-2.1525 -2.193 -4.2235 -3.4133
Net Income/Loss
101.25%
0.0268
-2.1525 -2.193 -4.2235 -3.4133
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
7.54%
4.2899
3.989 4.217 0.1152 4.215
Diluted Average Shares
9.34%
4.3617
3.989 4.217 0.0322 4.215
Basic Earnings Per Share
101.85%
0.01
-0.54 -0.52 -1.15 -0.81
Diluted Earnings Per Share
101.85%
0.01
-0.54 -0.52 -1.04 -0.81
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Capitalizzazione:     |  Volume (24 ore):